Manhattan Associates 株価情報 (NASDAQ: MANH)

Manhattan Associates (NASDAQ:MANH) 株価情報

Manhattan Associates

Manhattan Associates Inc provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers around the world.

Manhattan Associates, Inc. - Common Stock

Manhattan Associates Inc

Manhattan Bridge Capital, Inc - Common Stock

Manhattan Bridge Capital Inc

Manhattan Corp Ltd

MANHATTAN SCIENTIFICS INC by Manhattan Scientifics, Inc.

Manhattan Scientifics Inc

Truist Securities analyst Terry Tillman maintains Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) with a Buy and lowers the price target from $285 to $185.

News

Price Target

Analyst Ratings

MANH

Truist Securities Maintains Buy on Manhattan Associates, Lowers Price Target to $185

WIIM

ADBE

ADSK

DOCU

ESTC

FIVN

FTNT

GLOB

GWRE

HUBS

INTU

MSFT

NTNX

ORCL

OTEX

PANW

Shares of companies in the broader software sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

Across the recent three months, 11 analysts have shared their insights on Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>), expressing a variety of opinions spanning from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $244.91, a high estimate of $303.00, and a low estimate of $170.00. A 16.95% drop is evident in the current average compared to the previous average price target of $294.91. 
<img src="https://www.benzinga.com/files/images/story/2025/1744293666_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The analysis of recent analyst actions sheds light on the perception of Manhattan Associates by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Mark Schappel &#x7C;Loop Capital &#x7C;Lowers &#x7C;Hold &#x7C; $170.00&#x7C;$275.00 &#x7C; 
&#x7C;Joe Vruwink &#x7C;Baird &#x7C;Lowers &#x7C;Outperform &#x7C; $225.00&#x7C;$282.00 &#x7C; 
&#x7C;George Kurosawa &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $184.00&#x7C;$244.00 &#x7C; 
&#x7C;Quinton Gabrielli &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Overweight &#x7C; $200.00&#x7C;$268.00 &#x7C; 
&#x7C;Mark Schappel &#x7C;Loop Capital &#x7C;Lowers &#x7C;Buy &#x7C; $275.00&#x7C;$310.00 &#x7C; 
&#x7C;Gil Luria &#x7C;DA Davidson &#x7C;Lowers &#x7C;Buy &#x7C; $270.00&#x7C;$315.00 &#x7C; 
&#x7C;Brian Peterson &#x7C;Raymond James &#x7C;Lowers &#x7C;Outperform &#x7C; $270.00&#x7C;$305.00 &#x7C; 
&#x7C;Quinton Gabrielli &#x7C;Piper Sandler &#x7C;Lowers &#x7C;Overweight &#x7C; $268.00&#x7C;$326.00 &#x7C; 
&#x7C;Terry Tillman &#x7C;Truist Securities &#x7C;Lowers &#x7C;Buy &#x7C; $285.00&#x7C;$310.00 &#x7C; 
&#x7C;George Kurosawa &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $244.00&#x7C;$303.00 &#x7C; 
&#x7C;George Kurosawa &#x7C;Citigroup &#x7C;Lowers &#x7C;Neutral &#x7C; $303.00&#x7C;$306.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Manhattan Associates. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Manhattan Associates compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Manhattan Associates's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
To gain a panoramic view of Manhattan Associates's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MANH/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Manhattan Associates analyst ratings.</a>
<h2>Unveiling the Story Behind Manhattan Associates</h2>
Manhattan Associates Inc provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers around the world.
<h3>A Deep Dive into Manhattan Associates's Financials</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Over the 3M period, Manhattan Associates showcased positive performance, achieving a revenue growth rate of 7.36% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Manhattan Associates's net margin is impressive, surpassing industry averages. With a net margin of 18.77%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Manhattan Associates's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 16.64%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 6.6%, the company showcases effective utilization of assets.
Debt Management: Manhattan Associates's debt-to-equity ratio is below the industry average. With a ratio of 0.16, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Manhattan Associates Stock

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Wells Fargo raised Toast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>) price target from $30 to $39. Wells Fargo analyst Jeff Cantwell upgraded the rating from Underweight to Overweight. Toast shares closed at $34.38 on Wednesday. <a href="https://www.benzinga.com/quote/TOST/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Guggenheim slashed the price target for Neogen Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOG#NASDAQ">NEOG</a>) from $15 to $13. Guggenheim analyst Subbu Nambi maintained a Buy rating. Neogen shares closed at $5.02 on Wednesday. <a href="https://www.benzinga.com/quote/NEOG/analyst-ratings">See how other analysts view this stock.</a></li>
<li>UBS lowered BorgWarner Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWA#NYSE">BWA</a>) price target from $38 to $31. UBS analyst Joseph Spak downgraded the stock from Buy to Neutral. BorgWarner shares closed at $26.89 on Wednesday. See how other analysts <a href="https://www.benzinga.com/quote/BWA/analyst-ratings">view this stock</a>.</li>
<li>Truist Securities cut the price target for IQVIA Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) from $263 to $216. Truist Securities analyst Jailendra Singh maintained a Buy rating. IQVIA shares closed at $157.02 on Wednesday. <a href="https://www.benzinga.com/quote/IQV/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities cut the price target for Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) from $171 to $159. B of A Securities analyst Tim Anderson maintained a Neutral rating. Johnson &amp; Johnson shares closed at $150.97 on Wednesday. <a href="https://www.benzinga.com/quote/JNJ/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Loop Capital slashed Manhattan Associates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) price target from $275 to $170. Loop Capital analyst Mark Schappel downgraded the stock from Buy to Hold. Manhattan Associates shares settled at $166.26 on Wednesday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view </a><a href="https://www.benzinga.com/quote/MANH/analyst-ratings">this </a><a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">stock</a>.</li>
<li>Barclays cut ManpowerGroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAN#NYSE">MAN</a>) price target from $55 to $50. Barclays analyst Manav Patnaik upgraded the stock from Underweight to Equal-Weight. ManpowerGroup shares closed at $52.87 on Wednesday. <a href="https://www.benzinga.com/quote/MAN/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Truist Securities slashed Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) price target from $265 to $230. Truist Securities analyst Youssef Squali maintained a Buy rating. Amazon shares closed at $191.10 on Wednesday.  <a href="https://www.benzinga.com/quote/AMZN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Mizuho cut the price target for NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) from $4.2 to $3.5. Mizuho analyst Vijay Rakesh maintained a Neutral rating. NIO shares settled at $3.31 on Wednesday. <a href="https://www.benzinga.com/quote/NIO/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler slashed Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) price target from $208 to $185. Piper Sandler analyst Thomas Champion maintained an Overweight rating. Alphabet shares closed at $158.71 on Wednesday. <a href="https://www.benzinga.com/quote/googl/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying GOOGL stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="577" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10092133/image-69-1024x577.png" alt="" class="wp-image-865996" style="width:518px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10092133/image-69-1024x577.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10092133/image-69-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10092133/image-69-768x433.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/10092133/image-69.png 1103w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/25/04/44710375/top-2-materials-stocks-that-may-fall-off-a-cliff-this-quarter">Top 2 Materials Stocks That May Fall Off A Cliff This Quarter</a> </li>
</ul>
Photo via Shutterstock

Markets

Trading Ideas

AMZN

GOOGL

NEOG

TOST

Alphabet To $185? Here Are 10 Top Analyst Forecasts For Thursday

Loop Capital analyst Mark Schappel downgrades Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) from Buy to Hold and lowers the price target from $275 to $170.

Downgrades

Loop Capital Downgrades Manhattan Associates to Hold, Lowers Price Target to $170

ACIW

AEYE

ANSS

APPF

APPN

NICE

OPRA

QLYS

TEAM

UPLD

YEXT

Shares of software ant IT stocks are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

In the current market session, Manhattan Associates Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) share price is at $175.46, after a 0.09% decrease. Over the past month, the stock increased by 0.27%, but over the past year, it actually fell by 29.07%. With good short-term performance like this, and questionable long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.

<img src="https://www.benzinga.com/files/images/story/2025/1743102029_0_0.png" alt="Past Year Chart" />

<h3>Manhattan Associates P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 51.19 in the Software industry, Manhattan Associates Inc. has a lower P/E ratio of 50.03. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1743102029_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Price Over Earnings Overview: Manhattan Associates

Baird analyst Joe Vruwink maintains Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) with a Outperform and lowers the price target from $282 to $225.

Baird Maintains Outperform on Manhattan Associates, Lowers Price Target to $225

Citigroup analyst George Kurosawa maintains Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) with a Neutral and lowers the price target from $244 to $184.

Citigroup Maintains Neutral on Manhattan Associates, Lowers Price Target to $184

ASAN

BILL

CRWD

CVLT

CYBR

FICO

OKTA

PEGA

SAIL

SHOP

SNPS

TWLO

Shares of companies in the broader software sector are trading higher. The sector may be rising as the overall market rebounds after falling recently on tariff concerns.

Analysts' ratings for Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) over the last quarter vary from bullish to bearish, as provided by 9 analysts.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $269.0, a high estimate of $306.00, and a low estimate of $200.00. Observing a downward trend, the current average is 11.32% lower than the prior average price target of $303.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1741953657_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A clear picture of Manhattan Associates's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Quinton Gabrielli</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$200.00</td>
<td>$268.00</td>
</tr>
<tr>
<td>Mark Schappel</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$275.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$270.00</td>
<td>$315.00</td>
</tr>
<tr>
<td>Brian Peterson</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$270.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Quinton Gabrielli</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$268.00</td>
<td>$326.00</td>
</tr>
<tr>
<td>Terry Tillman</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$285.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>George Kurosawa</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$244.00</td>
<td>$303.00</td>
</tr>
<tr>
<td>George Kurosawa</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$303.00</td>
<td>$306.00</td>
</tr>
<tr>
<td>George Kurosawa</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$306.00</td>
<td>$287.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Manhattan Associates. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Manhattan Associates compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Manhattan Associates's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Manhattan Associates's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MANH/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Manhattan Associates analyst ratings.</a>
<h2>Unveiling the Story Behind Manhattan Associates</h2>
Manhattan Associates Inc provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers around the world.
<h3>A Deep Dive into Manhattan Associates's Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Manhattan Associates displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 7.36%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Manhattan Associates's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 18.77%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Manhattan Associates's ROE excels beyond industry benchmarks, reaching 16.64%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Manhattan Associates's ROA excels beyond industry benchmarks, reaching 6.6%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.16, Manhattan Associates adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For Manhattan Associates's Future

Piper Sandler analyst Quinton Gabrielli maintains Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) with a Overweight and lowers the price target from $268 to $200.

Piper Sandler Maintains Overweight on Manhattan Associates, Lowers Price Target to $200

ACMR

ANET

APLD

ARQQ

ATGL

AUUD

AVGO

AXTI

BBAI

BOXL

BZAI

CIEN

CIFR

CMTL

Core Scientific, Inc. - Class A Common Stock

CORZ

CRDO

CSAI

DELL

DOCN

GRRR

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IREN

IVDA

KLTR

LCFY

MARA

MLGO

MOBBW

MRVL

MSTR

MVIS

NCTY

ONDS

PCLA

PLTR

PONY

PRCH

QBTS

QMCO

RCAT

RGTI

SITM

SLNH

SMCI

SNOW

SOUN

STAI

TUYA

VEEA

VNET

Shares of companies within the broader tech sector are trading lower as investors react to last week's economic data and await key reports this week. Investor sentiment ahead of Nvidia's earnings report may set the tone for the sector.

Manhattan Associates's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NYSE">MANH</a>) short percent of float has fallen 35.23% since its last report. The company recently reported that it has 1.12 million shares sold short, which is 2.5% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.35 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Manhattan Associates Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1740158121_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Manhattan Associates has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Manhattan Associates's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Manhattan Associates's peer group average for short interest as a percentage of float is 5.59%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Peering Into Manhattan Associates's Recent Short Interest

Throughout the last three months, 9 analysts have evaluated Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>), offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Manhattan Associates, presenting an average target of $283.0, a high estimate of $326.00, and a low estimate of $244.00. This current average has decreased by 8.04% from the previous average price target of $307.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1739476813_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Manhattan Associates among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Schappel</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$275.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$270.00</td>
<td>$315.00</td>
</tr>
<tr>
<td>Brian Peterson</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$270.00</td>
<td>$305.00</td>
</tr>
<tr>
<td>Quinton Gabrielli</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$268.00</td>
<td>$326.00</td>
</tr>
<tr>
<td>Terry Tillman</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$285.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>George Kurosawa</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$244.00</td>
<td>$303.00</td>
</tr>
<tr>
<td>George Kurosawa</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$303.00</td>
<td>$306.00</td>
</tr>
<tr>
<td>George Kurosawa</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$306.00</td>
<td>$287.00</td>
</tr>
<tr>
<td>Quinton Gabrielli</td>
<td>Piper Sandler</td>
<td>Announces</td>
<td>Overweight</td>
<td>$326.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Manhattan Associates. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Manhattan Associates compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Manhattan Associates's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
For valuable insights into Manhattan Associates's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MANH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Manhattan Associates analyst ratings.</a>
<h2>Unveiling the Story Behind Manhattan Associates</h2>
Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers around the world.
<h3>Manhattan Associates: Delving into Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Challenges: Manhattan Associates's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -4.08%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Manhattan Associates's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 18.77% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Manhattan Associates's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 16.64%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 6.6%, the company showcases effective utilization of assets.
Debt Management: Manhattan Associates's debt-to-equity ratio is below the industry average. With a ratio of 0.16, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Significance of Analyst Ratings Explained</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

William Blair analyst Dylan Becker upgrades Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) from Market Perform to Outperform.

Upgrades

William Blair Upgrades Manhattan Associates to Outperform

Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) has outperformed the market over the past 10 years by 1.94% on an annualized basis producing an average annual return of 13.07%. Currently, Manhattan Associates has a market capitalization of $10.87 billion. 
Buying $100 In MANH: If an investor had bought $100 of MANH stock 10 years ago, it would be worth $341.55 today based on a price of $178.50 for MANH at the time of writing.
<h3>Manhattan Associates's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739287811_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today

Manhattan Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) shares traded lower on Monday. The software company announced that its president and CEO Eddie Capel <a href="https://www.benzinga.com//node/43592331">will retire.</a>
What To Know: The CEO of NTT Data North America, Eric Clark, will take over as CEO of Manhattan Associates. Capel, whose retirement is effective Feb. 12, will continue to serve Manhattan Associates in the role of executive vice chairman of the board, assisting with CEO transition and special projects. 
Capel joined Manhattan in June 2000, holding various operations and technology roles before being appointed COO in January 2011 and president and CEO in January 2013.
&#8220;Our company is in an exceptionally strong position strategically, competitively, operationally and financially. I want to thank our management team and our entire workforce, which is second to none, for their hard work and dedication to our mission of advancing global commerce through advanced technology,&#8221; said Capel.
&#8220;I look forward to working closely with Eric and continuing to contribute to our product vision, interacting with our customers and partners, and ensuring the growth and success of Manhattan Associates. And I have confidence that under Eric&#8217;s leadership, the team will continue to capitalize on our many market opportunities and extend our global leadership position.&#8221;
Before joining NTT Data North America, Clark held numerous senior leadership positions with ServiceNow, Dell, Hewlett Packard Enterprise, Arthur Andersen Business Consulting, Ernst &amp; Young and Bank of America.
Related Link: <a href="https://www.benzinga.com/25/02/43605478/buy-these-2-great-stocks-at-fire-sale-prices-while-you-still-can">Buy These 2 Great Stocks at Fire-Sale Prices While You Still Can</a>
MANH Price Action: Manhattan Associates stock closed Monday&#8217;s regular session 11.55% lower at $177.70, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: This illustration was generated using artificial intelligence via Midjourney.

Management

Movers

What's Going On With Manhattan Associates Stock Monday?

U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping more than 150 points on Monday.
The Dow traded up 0.40% to 44,482.54 while the NASDAQ gained 1.16% to 19,750.22. The S&amp;P 500 also rose, gaining, 0.75% to 6,071.29.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43559194/jim-cramer-likes-this-utilities-stock-i-think-youve-got-a-good-one">Jim Cramer Likes This Utilities Stock: &#8216;I Think You&#8217;ve Got A Good One&#8217;</a>
Leading and Lagging Sectors Energy shares surged by 2% on Monday.
In trading on Monday, financial shares fell by 0.6%.
Top Headline
U.S. consumer inflation expectations for the year ahead came in steady for a third straight month at 3% in January.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>SpringWorks Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWTX#NASDAQ">SWTX</a>) shares shot up 36% to $54.85 after announcing Merck KGaA is in advanced discussions to acquire the company.</li>
<li>Shares of Biodexa Pharmaceuticals Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>)got a boost, surging 42% to $5.78 after the company announced it received FDA fast-track designation for eRapa.</li>
<li>monday.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) shares were also up, gaining 28% to $331.46 after the company reported better-than-expected fourth-quarter financial results and first-quarter revenue outlook.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Pliant Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) shares dropped 59% to $3.1893. On Friday, Pliant Therapeutics announced it has voluntarily paused enrollment and dosing in the ongoing BEACON-IPF Phase 2b trial of bexotegrast in patients with idiopathic pulmonary fibrosis (IPF), a chronic lung disease that causes scarring and stiffening of the lung tissue.</li>
<li>Shares of Manhattan Associates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>) were down 11% to $179.24. The company announced its president and CEO Eddie Capel will retire.</li>
<li>Semtech Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) was down, falling 31% to $37.60 after Needham cut its price target on the stock from $74 to $54.</li>
</ul>
Commodities In commodity news, oil traded up 1.7% to $72.22 while gold traded up 1.7% at $2,935.20.
Silver traded up 0.2% to $32.515 on Monday, while copper rose 2.6% to $4.7060.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.58%, Germany's DAX 40 rose 0.57% and France's CAC 40 rose 0.52%. Spain's IBEX 35 Index rose 0.16%, while London's FTSE 100 rose 0.77%.
Asia Pacific Markets
Asian markets closed mostly higher on Monday, with Japan's Nikkei 225 gaining 0.04%, China's Shanghai Composite Index climbing 0.56%, Hong Kong's Hang Seng Index gaining 1.84% and India's BSE Sensex falling 0.70%.
Economics
U.S. consumer inflation expectations for the year ahead came in steady for a third straight month at 3% in January.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43593480/wall-streets-most-accurate-analysts-give-their-take-on-3-real-estate-stocks-with-over-6-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Real Estate Stocks With Over 6% Dividend Yields</a></li>
</ul>

Equities

Eurozone

Commodities

BDRX

MNDY

PLRX

SMTC

SWTX

Crude Oil Rises Sharply; Manhattan Associates Shares Slide

Manhattan Associates shares are trading lower. The company announced its president and CEO Eddie Capel will retire.

Legal

Press Releases

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Manhattan Associates

Law Offices of Frank R. Cruz Encourages Manhattan Associates, Inc. (MANH) Investors To Inquire About Securities Fraud Class Action

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Manhattan Associates

Kirby McInerney LLP Urges Investors in Manhattan Associates, Inc. (MANH) Inquire About Their Rights in Class Action Lawsuit

Manhattan Associates, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. April 28, 2025 Deadline to file Lead Plaintiff Motion.

MANH Investors Have the Opportunity to Lead the Manhattan Associates Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

MANHATTAN ASSOCIATES, INC. (NASDAQ: MANH) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Manhattan Associates, Inc. Investors of Upcoming Deadline

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Manhattan Associates

Kirby McInerney LLP Urges Investors in Manhattan Associates, Inc. (MANH) to Inquire About Their Rights in Class Action Lawsuit

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against AppLovin, Maravai, e.l.f. Beauty, and Manhattan Associates and Encourages Investors to Contact the Firm

Comments

Manhattan Associates

ニュース

パートナーシップ

ベンジンガ・グローバル